Aridis Pharmaceuticals Inc

NASDAQ:ARDS   10:05:13 AM EDT
2.14
+0.07 (+3.38%)
Earnings Announcements

Aridis Pharma Announces Q3 Loss Per Share Of $1.94

Published: 11/10/2021 13:17 GMT
Aridis Pharmaceuticals Inc (ARDS) - Aridis Pharmaceuticals Announces Third Quarter 2021 Results.
Q3 Loss per Share $1.94.
Q3 Revenue $400,000.
Revenue is expected to be $3.6 Million
Adjusted EPS is expected to be -$0.50

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.30

More details on our Analysts Page.